LAZZARI, ELISA
 Distribuzione geografica
Continente #
EU - Europa 1969
NA - Nord America 1060
AS - Asia 448
AF - Africa 2
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 3483
Nazione #
GB - Regno Unito 1161
US - Stati Uniti d'America 1004
DE - Germania 384
CN - Cina 338
IT - Italia 233
SE - Svezia 56
CA - Canada 55
DK - Danimarca 45
IN - India 35
TR - Turchia 30
UA - Ucraina 27
KR - Corea 15
FI - Finlandia 10
RU - Federazione Russa 10
TW - Taiwan 9
FR - Francia 8
GR - Grecia 8
NL - Olanda 6
JP - Giappone 5
BE - Belgio 4
ES - Italia 4
IR - Iran 4
SG - Singapore 4
CH - Svizzera 3
HK - Hong Kong 3
RO - Romania 3
AT - Austria 2
AU - Australia 2
EU - Europa 2
HR - Croazia 2
IL - Israele 2
SC - Seychelles 2
CO - Colombia 1
MK - Macedonia 1
MX - Messico 1
NO - Norvegia 1
PH - Filippine 1
PL - Polonia 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 3484
Città #
Southend 1143
Hanover 277
Milan 121
Wilmington 103
Dearborn 90
Ann Arbor 88
Beijing 76
Seattle 74
Princeton 73
Ashburn 62
Fairfield 60
Houston 41
Grafing 40
Woodbridge 37
Nanjing 36
Toronto 31
Chandler 26
Des Moines 26
Cambridge 25
Changsha 21
Jinan 21
Istanbul 19
Mountain View 19
Hangzhou 16
Zhengzhou 16
Nanchang 15
Redwood City 15
Hebei 14
New York 13
Ottawa 13
Guangzhou 12
Medford 12
Shenyang 12
Tianjin 12
San Diego 11
Falls Church 10
Ningbo 10
La Jolla 9
Fremont 8
Munich 8
Shanghai 8
Berlin 7
Redmond 7
Jiaxing 6
Lubbock 6
Phoenix 6
Andover 5
Norwalk 5
Taizhou 5
Brussels 4
Costa Mesa 4
Duncan 4
Haikou 4
Nutley 4
Rochester 4
Roxbury 4
Seoul 4
Singapore 4
Taipei 4
Taiyuan 4
Wenzhou 4
Wuhan 4
Athens 3
Atlanta 3
Boston 3
Chengdu 3
Cinisello Balsamo 3
Ernakulam 3
Kunming 3
Lanzhou 3
Menlo Park 3
Mumbai 3
Nürnberg 3
Tainan 3
Absecon 2
Barcelona 2
Bitonto 2
Bologna 2
Dallas 2
Delhi 2
Flensburg 2
Fuzhou 2
Hefei 2
Jülich 2
Mahé 2
Parma 2
Rho 2
Rome 2
Rozzano 2
San Jose 2
Serio 2
Sheffield 2
Silver Spring 2
Tampa 2
Torino 2
Vienna 2
Xian 2
Adana 1
Albany 1
Amsterdam 1
Totale 2907
Nome #
Multiple myeloma exploits Jagged1 and Jagged2 to promote intrinsic and bone marrow-dependent drug resistance 446
MECHANISMS OF DRUG-ESCAPE AND RELAPSE IN MULTIPLE MYELOMA: INTERPLAY BETWEEN ADAR1 AND NOTCH IN ABERRANT RNA EDITING 194
Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1 177
Notch signaling promotes drug resistance in multiple myeloma through the regulation of the CXCR4/SDF1α axis 174
Notch signaling drives multiple myeloma induced osteoclastogenesis 160
Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche 151
Notch receptors regulate multiple myeloma-driven osteoclastogenesis 140
Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma 140
Relationship of the oncogene Notch and CXCR4/SDF1 signaling in human epithelial ovarian cancer 111
Chemokine receptors as novel targets of the oncogene Notch1 in acute lymphoblastic leukemia 110
Promotion of human multiple myeloma cell growth in vitro and bone marrow invasion in vivo by Notch receptors and the CXCR4/SDF1 axis 110
Jagged1/2 inhibition promotes multiple myeloma cell sensitivity to Bortezomib in vitro, ex-vivo and in vivo in a novel zebrafish model 108
Notch signaling promotes bone marrow-induced drug resistance in multiple myeloma through the regulation of the CXCR4/CXCL12 system 102
The Notch pathway controls multiple myeloma crosstalk with the osteoclastogenic niche 97
AKT promotes the oncogenic Notch signaling in T-cell acute lymphoblastic leukemia 91
ADAR1-dependent RNA editing is a mechanism of therapeutic resistance in human plasma cell malignancies 91
The role of notch pathway in multiple myeloma progression toward IL-6 independence 90
The role of notch pathway in multiple myeloma associated drug resistance 87
PI3K/AKT signaling inhibits NOTCH1 lysosome-mediated degradation 85
AKT regulation of oncogenic Notch pathway in T-cell acute lymphoblastic leukemia 80
Understanding the interaction of human cancer cells with the surrounding microenvironment: the new challenge in modern oncology 77
Notch signaling and multiple myeloma: challenging endogenous and bone marrow-mediated drug resistance 76
Jagged-directed therapy in multiple myeloma: a new approach to interrupt the crosstalk between the tumor cell and the bone marrow microenvironment 75
Generation of a stable fluorescent cell cycle reporter myeloma cell line for real-time evaluation of microenvironment-responsive and drug-induced cell cycle alterations 74
Bone marrow-mediated drug resistance is promoted by Jagged-induced notch pathway in multiple myeloma 72
Bone marrow-mediated drug resistance is promoted by Jagged-induced Notch signaling in multiple myeloma 69
Multiple myeloma-associated drug resistance : targeting the Notch pathway 68
The Notch pathway drives the ability of the bone marrow niche to promote RNA editing in multiple myeloma 68
The Notch pathway controls multiple myeloma induced osteoclastogenesis 64
Notch targeting prevents multiple myeloma associated osteoclastogenesis 63
Notch signaling drives myeloma cells homing to the bone marrow by regulating the CXCR4/CXCL12 axis 62
The role of Notch in the regulation of osteoclastogenesis in multiple myeloma 61
Jagged-induced notch signaling promotes endogenous and bone marrow-mediated drug resistance in multiple myeloma 56
Notch signaling and multiple myeloma: challenging endogenous and bone marrow-mediated drug resistance 53
Notch signaling dysregulation promotes multiple myeloma-associated bone disease 46
Targeting Cancer Stem Cell Survival in Plasma Cell Leukemia with a Pan-BCL2 Inhibitor 43
Totale 3771
Categoria #
all - tutte 4441
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4441


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018417 0228052 3447 4915 11126629
2018/2019562 121494034 4455 3329 21404848
2019/2020819 90161565 6291 11955 861472746
2020/2021543 37421526 4127 1851 125547037
2021/2022904 71426167 6487 6965 967994109
2022/202389 672200 00 00 0000
Totale 3771